申请人:Active Pass Pharmaceuticals, Inc.
公开号:US20030191144A1
公开(公告)日:2003-10-09
Methods and compositions useful in the treatment of amyloidosis and conditions and diseases associated therewith, such as Alzheimer's disease, are provided. The methods involve administering to a subject in need thereof a pharmaceutical composition including one or more agents that modulate PPAR&agr; and/or PPAR&dgr; activity, resulting in an inhibition of &bgr;-amyloid production and/or release from cells of the subject, particularly brain cells.
提供了在治疗淀粉样变性及相关疾病和病况(如阿尔茨海默病)中有用的方法和组合物。这些方法涉及向需要治疗的对象施用包括一个或多个调节PPAR&agr;和/或PPAR&dgr;活性的药物组合物,导致抑制β-淀粉样蛋白从对象的细胞(尤其是脑细胞)中的产生和/或释放。